Mr Gordon Kennovin
Aptuit is a global pharmaceutical services company that delivers early to mid-phase drug development solutions to more than 800 companies by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry. From seven locations around the world, including our strategic partner in India, Aptuit assists clients by shortening their timelines and delivering on time, in full. We solve scientific problems through technical expertise and superior project management. We provide significant value to our clients by delivering high quality services that exceed regulatory compliance standards.
Aptuit services include:
• Drug Design & Discovery
• Preclinical Biosciences
• API Development and Manufacture
• Solid State Chemistry
• Solid, Oral and Sterile Dosage Form Development and Manufacture
• Clinical Sciences
• Aptuit INDiGO® - Accelerated Drug Development Program
• Integrated Drug Discovery and Development
Aptuit (Glasgow) are specialist providers of formulation development and GMP manufacture of sterile dosage products, both liquid and lyophilised, for use within pre-clinical and clinical trials.
Our dedicated formulation scientists are experts in the delivery of complex formulations for liquid and lyophilised product types for small organic molecules through to large macromolecules (peptides, proteins, oligonucleotides etc). This is supported by a team of dedicated analytical scientist who are able to develop, validate or transfer analytical methods for use in the development of the formulation.
Mrs Heidi Kingdon-Jones
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services.
For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCINGTM, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline.
AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.
Mr Michael Kruidenier
Penn is a provider of an integrated range of services to the global pharmaceutical industry. They provide consultancy on matters relating to CMC data and the role of the QP. Their core services are Pre-formulation studies, Formulation Development including expertise in poorly soluble molecules, Analytical Services including stability testing, Clinical Trials Supplies from phase I-IV and commercial supply. Penn is a leading provider of Hi Contaiment Solid Oral Dose Manufacturing and for clinical trial manufacturing/packing/labelling/distribution services. Penn has been FDA inspected 9 times in recent years and has 7 QPs on site.
Their product offer and experience is wide - including solid dose forms, liquids, semi solids and high containment processing. Dedicated Phase I and ISS teams
Penn services include:
CMC Consultancy, Formulation Development, Analytical Development, Clinical Trial Supply, Contract Manufacturing, Qualified Persons Release Services, Paediatrics Formulation and Manufacturing, Hi-Potency capabilities, Orphan drug expertise, More than 30 Years of specials, manufacturing expertise, Comparator Sourcing.
The above offerings are all under one roof providing a strong and easy communication channel between departments making developments, manufacturing and analytical processes.
Come and see us at booth #73